Skip to content
Gigantum.net
Software & security

Cassidy questions ‘odd’ White House move in pulling FDA nominee

Sen. Bill Cassidy (R-La.) questioned the Trump administration’s reasoning for pulling Food and Drug Administration (FDA) commissioner nominee Heidi Overton, saying he thought she had the support needed to be confirmed. “Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the…

· 393 words· updated November 18, 2026 at 10:59 AM
Senate Health, Education, Labor and Pensions Committee Chairman Bill Cassidy (R-La.) greets Heidi Overton, President Trump’s nominee for the Commissioner of Food and Drugs (FDA), is seen before her nomination hearing on Thursday, September 24, 2026.
Senate Health, Education, Labor and Pensions Committee Chairman Bill Cassidy (R-La.) greets Heidi Overton, President Trump’s nominee for the Commissioner of Food and Drugs (FDA), is seen before her nomination hearing on Thursday, September 24, 2026.

Sen. Bill Cassidy (R-La.) questioned the Trump administration’s reasoning for pulling Food and Drug Administration (FDA) commissioner nominee Heidi Overton, saying he thought she had the support needed to be confirmed.

“Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members,” Cassidy wrote on social platform X late Tuesday. “I believe she would have had the votes to pass out of committee and pass the full Senate.”

Cassidy, chair of the Senate health committee and a medical doctor, has been critical of many of the president’s nominees to lead U.S. health agencies, though he has ultimately supported them.

He had criticized Overton for supporting President Trump’s decision to recommend changes to the childhood vaccine schedule, but Cassidy said he had come around after she committed to “follow the science” in her role at the FDA.

“My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk,” Cassidy said. “Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.”

Democrats are set to take a sizable majority in the upper chamber next year, an obstacle for Trump to nominate his preferred political appointees.

Trump nominated Overton back in August, and she was set to receive a critical vote in the Committee on Health, Education, Labor and Pensions on Wednesday. The White House confirmed to The Hill it pulled her nomination Tuesday evening.

Overton is a prominent health adviser in Trump’s orbit, leading the White House Domestic Policy Council. She is a prominent supporter of Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again movement, and an opponent of abortion rights.

She drew criticism for a viral exchange while being questioned by senators where she would not answer whether the president was wrong about his past statements on vaccine safety.

Overton has remained anti-abortion and previously called the abortion drug mifepristone “dangerous,” Cassidy said senators were seeking assurances on the Trump administration’s commitments to the cause.

“The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues,” Cassidy wrote Tuesday. “The Administration withdrew Dr. Overton rather than make such commitments.”

Gathered from external sources. Rights to this text belong to whoever originally published it.

Wednesday, November 18, 2026

© 2026 Gigantum.net. Content gathered automatically from external sources; rights to each text belong to whoever originally published it.